Accellix (a bioMerieux company) Email Format
Biotechnology ResearchCalifornia, United States51-200 Employees
Accellix is a biotechnology research company based in San Jose, California, focused on immunophenotyping quality control and starting material characterization for blood collection centers and cell therapy development and manufacturing. The business emphasizes automation and standardization of flow cytometry to reduce manual variability and hands-on time, delivering rapid, reliable results in GMP suites or at the point of need. Its approach aims to make complex cellular analysis accessible at the site of use, supporting on-site workflows and more consistent analytical outputs for faster, more reliable progress in cell and gene therapy programs. Accellix operates as a mid-sized organization within the biotechnology research industry. Its customer base includes blood collection centers and organizations developing or manufacturing cell therapies that require standardized, timely flow cytometry data to inform quality control and manufacturing decisions. In January 2026, bioMérieux completed the acquisition of Accellix, bringing the company under full ownership within the group.